The emerging potential of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynaecology
Reference27 articles.
1. Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer;Oakman;Breast Cancer Res,2009
2. Poly(ADP-ribose): novel functions for an old molecule;Schreiber;Nat Rev Mol Cell Biol,2006
3. Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361;Calabrese;J Natl Cancer Inst,2004
4. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature,2005
5. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Introducing Novel Molecular-based Method for Quantification of Homologous Recombination Efficiency;2021-01-19
2. Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities;Medicinal Research Reviews;2017-05-16
3. Overview of DNA repair pathways, current targets, and clinical trials bench to clinic;DNA Repair in Cancer Therapy;2016
4. A novel carbohydrate derived compound FCP5 causes DNA strand breaks and oxidative modifications of DNA bases in cancer cells;Chemico-Biological Interactions;2015-02
5. Oxidatively induced DNA damage and its repair in cancer;Mutation Research/Reviews in Mutation Research;2015-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3